Brief Information of the Cell Line and Protein
Cell Line ID: CL000154 , HEK293-EBNA1-6E
Synonyms
HEK 293EBNA1-6E
HEK293-6E
HEK2936E
293-6E
293FEt-clone 6E
Category Transformed cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_HF20
Protein ID: PT00911 , Melanocyte-stimulating hormone receptor
Gene Name MC1R
Organism Homo sapiens, Human
Protein Classification Membrane receptor
Uniprot ID Q01726
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL000154  Protein ID: PT00911
 
Compound ID Compound Name Compound Formula
CP0091326
(3S,6S,9R,12S,15S,23S)-15-((S)-2-acetylamino-hexanoylamino)-9-benzyl-6-(3-guanidino-propyl)-12-(3H-imidazol-4-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18hexaaza-cyclotricosane-23-carboxylic acid amide
   Show/Hide
C50H69N15O9
 1
1
EC50 < 0.03162 nM
   TI
   LI
   LO
   TS
CP0943602
2-[(1R,4S,10S,13S,16S,19S,22S,25S,28R,31S,34S,37S,40S,43S,49Z)-49-[2-[2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]ethylamino]-2-oxo-ethoxy]imino-13,34-dibenzyl-4-butyl-16,25,37,43-tetrakis(3-guanidinopropyl)-10,31-bis(1H-imidazol-5-ylmethyl)-19,40-bis(1H-indol-3-ylmethyl)-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44-pentadecaoxo-47,51-dithia-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45-pentadecazabicyclo[26.17.7]dopentacontan-22-yl]acetic acid
   Show/Hide
C107H150N38O22S2
 1
1
EC50 = 0.04677 nM
   TI
   LI
   LO
   TS
CP0455645
BREMELANOTIDE
   Show/Hide
C50H68N14O10
 1
1
EC50 = 0.07762 nM
   TI
   LI
   LO
   TS
CP0915717
2-[(1R,4S,7S,10S,13S,16S,19S,25S,28R,31S,34S,37S,40S,43S)-16,40-dibenzyl-25-butyl-4,13,31,37-tetrakis(3-carbamimidamidopropyl)-50-hex-5-ynyl-19,43-bis(1H-imidazol-5-ylmethyl)-10,34-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,49,51-heptadecaoxo-47,53-dithia-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,50-hexadecazatricyclo[26.17.9.048,52]tetrapentacont-48(52)-en-7-yl]acetic acid
   Show/Hide
C104H136N34O19S2
 1
1
EC50 = 0.08128 nM
   TI
   LI
   LO
   TS
CP0912341
2-[(1R,4S,7S,10S,13S,16S,19S,25S,28R,31S,34S,37S,40S,43S)-16,40-dibenzyl-25-butyl-4,13,31,37-tetrakis(3-carbamimidamidopropyl)-19,43-bis(1H-imidazol-5-ylmethyl)-10,34-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45-pentadecaoxo-47,55-dithia-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44-pentadecazatricyclo[26.17.11.149,53]heptapentaconta-49,51,53(57)-trien-7-yl]acetic acid
   Show/Hide
C102H135N33O17S2
 1
1
EC50 = 0.0871 nM
   TI
   LI
   LO
   TS
CP0952830
2-[(1R,4S,7S,10S,13S,16S,19S,25S,28R,31S,34S,37S,40S,43S)-16,40-dibenzyl-25-butyl-4,13,31,37-tetrakis(3-carbamimidamidopropyl)-19,43-bis(1H-imidazol-5-ylmethyl)-10,34-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45-pentadecaoxo-47,54-dithia-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44-pentadecazatricyclo[26.17.10.249,52]heptapentaconta-49,51,56-trien-7-yl]acetic acid
   Show/Hide
C102H135N33O17S2
 1
1
EC50 = 0.08913 nM
   TI
   LI
   LO
   TS
CP0965298
3-[2-[2-[2-[2-[[(1R,4S,7S,10S,13S,16S,19S,25S,28R,31S,34S,37S,40S,43S)-16,40-dibenzyl-25-butyl-4,13,31,37-tetrakis(3-carbamimidamidopropyl)-7-(carboxymethyl)-19,43-bis(1H-imidazol-5-ylmethyl)-10,34-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45-pentadecaoxo-47,59-dithia-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,61,62-heptadecazapentacyclo[26.17.15.248,58.049,57.052,54]dohexaconta-48(62),49(57),58(61)-trien-53-yl]methoxycarbonylamino]ethoxy]ethoxy]ethoxy]ethoxy]propanoic acid
   Show/Hide
C118H162N36O25S2
 1
1
EC50 = 0.08913 nM
   TI
   LI
   LO
   TS
CP0915720
2-[(1R,4S,7S,10S,13S,16S,19S,25S,28R,31S,34S,37S,40S,43S)-16,40-dibenzyl-25-butyl-4,13,31,37-tetrakis(3-carbamimidamidopropyl)-49,50,54,55-tetrafluoro-19,43-bis(1H-imidazol-5-ylmethyl)-10,34-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45-pentadecaoxo-47,52-dithia-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44-pentadecazatricyclo[26.17.8.248,51]pentapentaconta-48,50,54-trien-7-yl]acetic acid
   Show/Hide
C100H127F4N33O17S2
 1
1
EC50 = 0.123 nM
   TI
   LI
   LO
   TS
CP0915721
2-[(1R,4S,10S,13S,16S,19S,22S,25S,28R,31S,34S,37S,40S,43S)-13,34-dibenzyl-4-butyl-16,25,37,43-tetrakis(3-guanidinopropyl)-10,31-bis(1H-imidazol-5-ylmethyl)-19,40-bis(1H-indol-3-ylmethyl)-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44-pentadecaoxo-47,48-dithia-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45-pentadecazabicyclo[26.17.4]nonatetracontan-22-yl]acetic acid
   Show/Hide
C97H133N33O17S2
 1
1
EC50 = 0.1413 nM
   TI
   LI
   LO
   TS
CP0944140
SETMELANOTIDE
   Show/Hide
C49H68N18O9S2
 1
1
EC50 = 0.1585 nM
   TI
   LI
   LO
   TS
CP0941109
2-[(1R,4S,7S,10S,13S,16S,19S,25S,28R,31S,34S,37S,40S,43S)-16,40-dibenzyl-25-butyl-4,13,31,37-tetrakis(3-carbamimidamidopropyl)-19,43-bis(1H-imidazol-5-ylmethyl)-10,34-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45-pentadecaoxo-47,56-dithia-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44-pentadecazatricyclo[26.17.12.049,54]heptapentaconta-49,51,53-trien-7-yl]acetic acid
   Show/Hide
C102H135N33O17S2
 1
1
EC50 = 0.195 nM
   TI
   LI
   LO
   TS
CP0947448
2-[(1R,4S,7S,10S,13S,16S,19S,25S,28R,31S,34S,37S,40S,43S)-16,40-dibenzyl-25-butyl-4,13,31,37-tetrakis(3-carbamimidamidopropyl)-19,43-bis(1H-imidazol-5-ylmethyl)-10,34-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,49,51-heptadecaoxo-47,53-dithia-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,50-hexadecazatricyclo[26.17.9.048,52]tetrapentacont-48(52)-en-7-yl]acetic acid
   Show/Hide
C98H128N34O19S2
 1
1
EC50 = 0.2884 nM
   TI
   LI
   LO
   TS
CP0964686
2-((1R,4S,7S,10S,13S,16S,19S,25S,28R,31S,34S,37S,40S,43S)-19,43-bis((1H-imidazol-5-yl)methyl)-10,34-bis((1H-indol-3-yl)methyl)-16,40-dibenzyl-25-butyl-4,13,31,37-tetrakis(3-guanidinopropyl)-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45-pentadecaoxo-47,48-dithia-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44-pentadecaazabicyclo[26.17.4]nonatetracontan-7-yl)acetic acid
   Show/Hide
C94H127N33O17S2
 1
1
EC50 = 0.3388 nM
   TI
   LI
   LO
   TS
CP0943601
(1R,4S,7S,10S,13S,16S,19S,25S,28R,31S,34S,37S,40S,43S,48Z)-16,40-dibenzyl-25-butyl-48-carbamoyl-7-(carboxymethyl)-4,13,31,37-tetrakis(3-guanidinopropyl)-19,43-bis(1H-imidazol-5-ylmethyl)-10,34-bis(1H-indol-3-ylmethyl)-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45-pentadecaoxo-47,50-dithia-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44-pentadecazabicyclo[26.17.6]henpentacont-48-ene-49-carboxylic acid
   Show/Hide
C98H130N34O20S2
 1
1
EC50 = 0.4786 nM
   TI
   LI
   LO
   TS
CP0915659
2-[(1R,4S,10S,13S,16S,19S,22S,25S,28R,31S,34S,37S,40S,43S)-13,34-dibenzyl-4-butyl-16,25,37,43-tetrakis(3-guanidinopropyl)-10,31-bis(1H-imidazol-5-ylmethyl)-19,40-bis(1H-indol-3-ylmethyl)-2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,49-hexadecaoxo-47,51-dithia-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45-pentadecazabicyclo[26.17.7]dopentacontan-22-yl]acetic acid
   Show/Hide
C97H131N33O18S2
 1
1
EC50 = 0.5495 nM
   TI
   LI
   LO
   TS
CP0954451
(12S,4S,7R,17R,20S,23S,26S,29S,32S)-23-((1H-imidazol-5-yl)methyl)-32-((1H-indol-3-yl)methyl)-17-acetamido-26-benzyl-4-((S)-sec-butyl)-29-(3-guanidinopropyl)-20-((R)-1-hydroxyethyl)-28-methyl-2,5,18,21,24,27,30,33-octaoxo-10,14-dithia-3,6,19,22,25,28,31-heptaaza-1(2,1)-pyrrolidina-12(1,3)-benzenacyclotritriacontaphane-7-carboxamide
   Show/Hide
C66H90N16O11S2
 1
1
EC50 = 1.622 nM
   TI
   LI
   LO
   TS
CP0952828
(6S,9S,12S,15S,18S,21R,32R,35S,37aS)-15-((1H-imidazol-5-yl)methyl)-6-((1H-indol-3-yl)methyl)-21-acetamido-12-benzyl-35-((S)-sec-butyl)-9-(3-guanidinopropyl)-18-((R)-1-hydroxyethyl)-10-methyl-5,8,11,14,17,20,34,37-octaoxo-2,3,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,24,29,31,32,33,34,35,36,37,37a-triacontahydro-1H-benzo[e1]pyrrolo[2,1-i][1,29]dithia[4,7,10,13,16,19,22,25]octaazacyclotritriacontine-32-carboxamide
   Show/Hide
C64H86N16O11S2
 1
1
EC50 = 1.862 nM
   TI
   LI
   LO
   TS
CP0915719
(6S,9S,12S,15S,18S,21R,34R,37S,39aS)-15-((1H-imidazol-5-yl)methyl)-6-((1H-indol-3-yl)methyl)-21-acetamido-12-benzyl-37-((S)-sec-butyl)-9-(3-guanidinopropyl)-18-((R)-1-hydroxyethyl)-10-methyl-5,8,11,14,17,20,36,39-octaoxo-1,2,3,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,25,30,32,33,34,35,36,37,38,39,39a-dotriacontahydro-5H-benzo[g1]pyrrolo[2,1-j][1,31]dithia[5,8,11,14,17,20,23,26]octaazacyclopentatriacontine-34-carboxamide
   Show/Hide
C66H90N16O11S2
 1
1
EC50 = 2.138 nM
   TI
   LI
   LO
   TS
CP0944876
(12S,4S,7R,15R,18S,21S,24S,27S,30S)-21-((1H-imidazol-5-yl)methyl)-30-((1H-indol-3-yl)methyl)-15-acetamido-24-benzyl-4-((S)-sec-butyl)-27-(3-guanidinopropyl)-18-((R)-1-hydroxyethyl)-26-methyl-2,5,16,19,22,25,28,31-octaoxo-9,13-dithia-3,6,17,20,23,26,29-heptaaza-1(2,1)-pyrrolidina-11(1,3)-benzenacyclohentriacontaphane-7-carboxamide
   Show/Hide
C64H86N16O11S2
 1
1
EC50 = 2.951 nM
   TI
   LI
   LO
   TS
CP0953392
(12S,4S,7R,17R,20S,23S,26S,29S,32S)-23-((1H-imidazol-5-yl)methyl)-32-((1H-indol-3-yl)methyl)-17-acetamido-26-benzyl-4-((S)-sec-butyl)-29-(3-guanidinopropyl)-20-((R)-1-hydroxyethyl)-28-methyl-2,5,18,21,24,27,30,33-octaoxo-10,14-dithia-3,6,19,22,25,28,31-heptaaza-1(2,1)-pyrrolidina-12(1,4)-benzenacyclotritriacontaphane-7-carboxamide
   Show/Hide
C66H90N16O11S2
 1
1
EC50 = 3.981 nM
   TI
   LI
   LO
   TS
CP0952829
(3S,6R,13R,16S,19S,22S,25S,28S,33aS)-19-((1H-imidazol-5-yl)methyl)-28-((1H-indol-3-yl)methyl)-13-acetamido-22-benzyl-3-((S)-sec-butyl)-25-(3-guanidinopropyl)-16-((R)-1-hydroxyethyl)-24-methyl-1,4,14,17,20,23,26,29-octaoxotriacontahydro-11H-pyrrolo[2,1-k][1,2]dithia[6,9,12,15,18,21,24,27]octaazacyclohentriacontine-6-carboxamide
   Show/Hide
C58H82N16O11S2
 1
1
EC50 = 4.786 nM
   TI
   LI
   LO
   TS
CP0912401
(12S,4S,7R,15R,18S,21S,24S,27S,30S)-21-((1H-imidazol-5-yl)methyl)-30-((1H-indol-3-yl)methyl)-15-acetamido-24-benzyl-4-((S)-sec-butyl)-27-(3-guanidinopropyl)-18-((R)-1-hydroxyethyl)-26-methyl-2,5,16,19,22,25,28,31-octaoxo-9,13-dithia-3,6,17,20,23,26,29-heptaaza-1(2,1)-pyrrolidina-11(1,4)-benzenacyclohentriacontaphane-7-carboxamide
   Show/Hide
C64H86N16O11S2
 1
1
EC50 = 5.129 nM
   TI
   LI
   LO
   TS
CP0950547
(3S,6S,9S,12S,15S,18R,23R,26S,29S)-18-acetamido-9-benzyl-6-(3-guanidinopropyl)-15-[(1R)-1-hydroxyethyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-7-methyl-26-[(1S)-1-methylpropyl]-2,5,8,11,14,17,25,28-octaoxo-20,21-dithia-1,4,7,10,13,16,24,27-octazabicyclo[27.3.0]dotriacontane-23-carboxamide
   Show/Hide
C56H78N16O11S2
 1
1
EC50 = 8.71 nM
   TI
   LI
   LO
   TS